Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

Wagner, Nikolaus B.; Weide, Benjamin; Gries, Mirko; Reith, Maike; Tarnanidis, Kathrin; Schuermans, Valerie; Kemper, Charlotte; Kehrel, Coretta; Funder, Anne; Lichtenberger, Ramtin; Sucker, Antje; Herpel, Esther; Holland-Letz, Tim; Schadendorf, Dirk; Garbe, Claus; Umansky, Viktor; Utikal, Jochen; Gebhardt, Christoffer

dc.contributor.author	Wagner, Nikolaus B.
dc.contributor.author	Weide, Benjamin Matthias
dc.contributor.author	Garbe, Claus
dc.date.accessioned	2020-07-09T13:32:06Z
dc.date.available	2020-07-09T13:32:06Z
dc.date.issued	2019
dc.identifier.issn	2051-1426
dc.identifier.uri	http://hdl.handle.net/10900/102548
dc.language.iso	en	de_DE
dc.publisher	Bmc	de_DE
dc.relation.uri	http://dx.doi.org/10.1186/s40425-019-0828-1	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200409032300_00112
utue.personen.roh	Wagner, Nikolaus B.
utue.personen.roh	Weide, Benjamin
utue.personen.roh	Gries, Mirko
utue.personen.roh	Reith, Maike
utue.personen.roh	Tarnanidis, Kathrin
utue.personen.roh	Schuermans, Valerie
utue.personen.roh	Kemper, Charlotte
utue.personen.roh	Kehrel, Coretta
utue.personen.roh	Funder, Anne
utue.personen.roh	Lichtenberger, Ramtin
utue.personen.roh	Sucker, Antje
utue.personen.roh	Herpel, Esther
utue.personen.roh	Holland-Letz, Tim
utue.personen.roh	Schadendorf, Dirk
utue.personen.roh	Garbe, Claus
utue.personen.roh	Umansky, Viktor
utue.personen.roh	Utikal, Jochen
utue.personen.roh	Gebhardt, Christoffer
dcterms.isPartOf.ZSTitelID	Journal For Immunotherapy of Cancer	de_DE
dcterms.isPartOf.ZS-Issue	Article 343	de_DE
dcterms.isPartOf.ZS-Volume	7	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE